hereditary cancer
Genetic Testing Challenges in Oncology: VHL Variant in Atypical Patient Raises Management Questions
Multi-gene testing uncovers a pathogenic VHL variant in a 30-year-old woman with inconsistent personal and family cancer history putting her on an aggressive screening schedule.
Study Secures EGFR Mutation's Role in Inherited Lung Cancer Risk; Raises Questions About Guidelines
Premium
In a prospective study, patients with an EGFR T790M somatic mutation at diagnosis had a 50 percent chance of having a germline mutation, suggesting the need for more specific guidelines.
AccessHope Real-World Data Study Identifies Molecular Testing Gaps in Pancreatic Cancer Care
Premium
Out of around 100 cases reviewed by subspecialists, most completed recommended, guideline-concordant germline and somatic testing, but many still did not.
FDA Grants Marketing Authorization for Invitae Hereditary Cancer DNA Sequencing Test
The Invitae Common Hereditary Cancers Panel is the first test of its kind to obtain FDA marketing authorization, creating an easier pathway for similar tests.
Genetic Technologies Partners With Aussie Hospital on Precision Medicine Pilot Study
Gold Coast Private Hospital will use Genetic Technologies' PGx and disease risk tests with a pilot study aiming to establish clinical workflows and results reporting at its precision medicine clinic.